Newsfeeds - Spark Newswire

1 minute read

Events
News

Akebia Announces Vadadustat Efficacy And Safety Data To Be Presented At American Society Of Nephrology Kidney Week 2021

Today, 11:21 AM

Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced that vadadustat efficacy and safety data related to clinical outcomes among patients with anemia due to chronic kidney disease (CKD) will be presented at the

AKBA

1 minute read

After FDA Rejection, EMA Approves FibroGen-Astellas’ Roxadustat

By Vandana Singh

Today, 11:21 AM

The European Commission (EC) has approved FibroGen Inc (NASDAQ:FGEN) and Astellas Pharma’s (OTC:ALPMF) Evrenzo (roxadustat) for anemia caused by chronic kidney disease (CKD),…

AKBA

8 minute read

99 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:21 AM

Gainers

ACAD

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 11:21 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 11:21 AM

AKBA

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 11:21 AM

Gainers

AKBA

1 minute read

FDA
News

Akebia Therapeutics Posts Study Titled ‘Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants (IMPACT)’ To ClinicalTrials.Gov

By Benzinga Newsdesk

Today, 11:21 AM

https://clinicaltrials.gov/ct2/show/NCT04922645

AKBA

1 minute read

Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise

By Vandana Singh

Today, 11:21 AM

Cyclerion Therapeutics Inc (NASDAQ:CYCN) has entered into an exclusive, global license agreement with Akebia Therapeutics Inc (NASDAQ:AKBA) for the development and commercialization of…

AKBA

1 minute read

Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related Anemia

By Vandana Singh

Today, 11:21 AM

Akebia Therapeutics Inc (NASDAQ:AKBA) and its collaborator Otsuka Holdings (OTC:OTSKY) have announced that the FDA has accepted to review vadadustat’s marketing application for…

AKBA

13 minute read

Uncategorized

Earnings Scheduled For May 10, 2021

By Benzinga Insights

Today, 11:21 AM

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.

ACEL